Last reviewed · How we verify
ICXP007
ICXP007 is an engineered collagen-based scaffold designed to promote tissue regeneration and wound healing.
ICXP007 is an engineered collagen-based scaffold designed to promote tissue regeneration and wound healing. Used for Chronic wounds, Tissue regeneration.
At a glance
| Generic name | ICXP007 |
|---|---|
| Sponsor | Intercytex |
| Drug class | Tissue engineering scaffold / Regenerative medicine product |
| Modality | Small molecule |
| Therapeutic area | Regenerative Medicine / Wound Care |
| Phase | Phase 3 |
Mechanism of action
ICXP007 functions as a bioengineered extracellular matrix substitute that provides structural support for cell migration, proliferation, and differentiation. The collagen scaffold is designed to be gradually resorbed while new tissue forms, facilitating natural tissue regeneration in chronic wounds and other tissue defects.
Approved indications
- Chronic wounds
- Tissue regeneration
Common side effects
- Local inflammation at application site
- Infection risk
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |